Qiagen (QGEN) Competitors

Danaher (NYSE:DHR) and Qiagen (NYSE:QGEN) are both large-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, media sentiment, profitability, analyst recommendations, institutional ownership, earnings, valuation and dividends.

Do analysts prefer DHR or QGEN?

Danaher currently has a consensus target price of $248.43, suggesting a potential upside of 21.31%. Qiagen has a consensus target price of $49.40, suggesting a potential upside of 2.64%. Given Danaher's stronger consensus rating and higher possible upside, equities research analysts clearly believe Danaher is more favorable than Qiagen.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Danaher	0 Sell rating(s)	3 Hold rating(s)	17 Buy rating(s)	0 Strong Buy rating(s)	2.85
Qiagen	0 Sell rating(s)	7 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.30

Which has more risk and volatility, DHR or QGEN?

Danaher has a beta of 0.77, meaning that its stock price is 23% less volatile than the S&P 500. Comparatively, Qiagen has a beta of 0.68, meaning that its stock price is 32% less volatile than the S&P 500.

Does the media prefer DHR or QGEN?

In the previous week, Danaher had 36 more articles in the media than Qiagen. MarketBeat recorded 39 mentions for Danaher and 3 mentions for Qiagen. Danaher's average media sentiment score of 1.56 beat Qiagen's score of 0.70 indicating that Danaher is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Danaher	34 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Qiagen	2 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Is DHR or QGEN more profitable?

Danaher has a net margin of 15.81% compared to Qiagen's net margin of 4.68%. Qiagen's return on equity of 14.61% beat Danaher's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Danaher	15.81%	10.80%	6.89%
Qiagen	4.68%	14.61%	8.80%

Which has preferable valuation & earnings, DHR or QGEN?

Danaher has higher revenue and earnings than Qiagen. Danaher is trading at a lower price-to-earnings ratio than Qiagen, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Danaher	$23.88B	6.14	$3.90B	$5.15	39.77
Qiagen	$2.00B	5.34	$83.59M	$0.40	120.33

Is DHR or QGEN a better dividend stock?

Danaher pays an annual dividend of $1.28 per share and has a dividend yield of 0.6%. Qiagen pays an annual dividend of $0.25 per share and has a dividend yield of 0.5%. Danaher pays out 24.9% of its earnings in the form of a dividend. Qiagen pays out 62.5% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Danaher has increased its dividend for 2 consecutive years. Danaher is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Do institutionals and insiders hold more shares of DHR or QGEN?

79.1% of Danaher shares are owned by institutional investors. Comparatively, 70.0% of Qiagen shares are owned by institutional investors. 11.1% of Danaher shares are owned by company insiders. Comparatively, 9.0% of Qiagen shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Summary

Danaher beats Qiagen on 16 of the 19 factors compared between the two stocks.